LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Revenue

LENZ Therapeutics had revenue of $3.38M in the quarter ending September 30, 2026, a decrease of -72.93%. This brings the company's total for the last twelve months to $12.36M, down -29.38% year-over-year. In the year 2025, LENZ Therapeutics had annual revenue of $19.09M. That makes LENZ Therapeutics the 36,435th largest company in the world by revenue and 4,778th in the United States.

• Revenue (ttm): $12.36M
• Revenue Growth: -29.38%
• P/S Ratio: 10.91
• Revenue / Employee: $308,975
• Employees: 40
• Market Cap: 134.79M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.09M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	15.00M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error